XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 21 filers reported holding XENON PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $230 | -88.1% | 5,000 | -90.8% | 0.01% | -86.7% |
| Q1 2023 | $1,938 | -98.0% | 54,140 | +71.9% | 0.04% | +1025.0% |
| Q2 2017 | $99,000 | -21.4% | 31,500 | 0.0% | 0.00% | -20.0% |
| Q1 2017 | $126,000 | -48.1% | 31,500 | 0.0% | 0.01% | -58.3% |
| Q4 2016 | $243,000 | -4.7% | 31,500 | 0.0% | 0.01% | -25.0% |
| Q3 2016 | $255,000 | +33.5% | 31,500 | -2.8% | 0.02% | +6.7% |
| Q2 2016 | $191,000 | -46.3% | 32,400 | -36.5% | 0.02% | 0.0% |
| Q1 2016 | $356,000 | -1.7% | 51,000 | +13.3% | 0.02% | -40.0% |
| Q4 2015 | $362,000 | +3.4% | 45,000 | +6.1% | 0.02% | +66.7% |
| Q3 2015 | $350,000 | – | 42,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,754,266 | $107,388,831 | 7.33% |
| Altium Capital Management LP | 360,600 | $14,059,794 | 5.74% |
| Affinity Asset Advisors, LLC | 994,227 | $38,764,911 | 4.47% |
| First Light Asset Management, LLC | 1,306,260 | $50,931,077 | 4.46% |
| Nan Fung Group Holdings Ltd | 106,680 | $4,159,453 | 4.44% |
| Ally Bridge Group (NY) LLC | 169,369 | $6,603,697 | 3.93% |
| TLS Advisors LLC | 32,956 | $1,285 | 3.22% |
| BRAIDWELL LP | 2,560,573 | $99,836,741 | 3.13% |
| Paradigm Biocapital Advisors LP | 2,043,280 | $79,667,487 | 3.05% |
| BRIDGER MANAGEMENT, LLC | 146,800 | $5,723,732 | 2.94% |